文献速递青光眼

眼压多基因风险评分可分层原发性开角型青光眼多项参数包括治疗强度

An Intraocular Pressure Polygenic Risk Score Stratifies Multiple Primary Open-Angle Glaucoma Parameters Including Treatment Intensity.
PubMed 文献 · Ophthalmology · 2020-01-07

本研究基于眼压相关基因变异构建多基因风险评分(PRS),在2154例晚期原发性开角型青光眼(POAG)患者中分析其与青光眼表型的关联,并在624例早期POAG患者中重复验证。结果显示IOP PRS与最高记录眼压、诊断年龄、受累家属数及手术需求呈剂量-反应关系,提示眼压介导的通路基因聚合效应对青光眼临床管理有重要意义。

要点

  • IOP PRS高分位组最高眼压较低分位组高1.7 mmHg(SD 0.62,P=0.006)。
  • 高遗传风险组诊断年龄早3.7年(SD 1.0,P<0.001),受累家属多0.46人(SD 0.11,P<0.001)。
  • 高遗传风险组切开手术率更高(OR 1.5,95%CI 1.1-2.0,P=0.007)。

核心结论

  • IOP PRS与最高眼压、疾病严重程度、手术需求及受累家属数呈正相关,具有临床意义和可重复性。

研究设计与样本

  • 横断面研究,主要分析纳入澳大利亚和新西兰晚期青光眼登记处2154例POAG患者(含英国招募患者),重复队列为624例早期POAG患者。
  • 利用眼压全基因组关联研究汇总统计量构建仅基于眼压相关变异的PRS,将POAG患者分为3个风险层级:最低和最高五分位分别为低危和高危组,其余五分位为中危组。

主要发现

  • IOP PRS与最高记录眼压呈剂量-反应关系,高危组较低危组最高眼压高1.7 mmHg(SD 0.62 mmHg,P=0.006)。
  • 高危组较低危组诊断年龄早3.7年(SD 1.0年,P<0.001),受累家属多0.46人(SD 0.11人,P<0.001)。
  • 高危组较低危组切开手术率更高(OR 1.5,95%CI 1.1-2.0,P=0.007)。
  • 视野平均偏差(mean deviation)组间差异无统计学意义。
  • 在早期POAG队列中重复验证了最高眼压、受累家属数及治疗强度(用药数量)结果(P≤0.01)。

关键数值与推荐

  • PRS风险分层依据:最低五分位为低危组,最高五分位为高危组,其余五分位为中危组。
  • 主要结局包括最高记录眼压、诊断年龄、受累家属数、杯盘比、视野平均偏差及治疗强度。

临床怎么用

  • IOP PRS可用于POAG患者风险分层,高分者可能需更密切监测眼压和更积极治疗。
  • 对高危遗传风险患者的近亲家属可考虑加强青光眼筛查和遗传咨询。

局限性

  • 横断面设计无法推断因果关系。
  • PRS仅基于眼压相关变异,未涵盖非眼压通路基因。
  • 重复队列样本量较小(624例),部分结果未在重复队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the combined effects of common genetic variants associated with intraocular pressure (IOP) on primary open-angle glaucoma (POAG) phenotype using a polygenic risk score (PRS) stratification. DESIGN: Cross-sectional study. PARTICIPANTS: For the primary analysis, we examined the glaucoma phenotype of 2154 POAG patients enrolled in the Australian and New Zealand Registry of Advanced Glaucoma, including patients recruited from the United Kingdom. For replication, we examined an independent cohort of 624 early POAG patients. METHODS: Using IOP genome-wide association study summary statistics, we developed a PRS derived solely from IOP-associated variants and stratified POAG patients into 3 risk tiers. The lowest and highest quintiles of the score were set as the low- and high-risk groups, respectively, and the other quintiles were set as the intermediate risk group. MAIN OUTCOME MEASURES: Clinical glaucoma phenotype including maximum recorded IOP, age at diagnosis, number of family members affected by glaucoma, cup-to-disc ratio, visual field mean deviation, and treatment intensity. RESULTS: A dose-response relationship was found between the IOP PRS and the maximum recorded IOP, with the high genetic risk group having a higher maximum IOP by 1.7 mmHg (standard deviation [SD], 0.62 mmHg) than the low genetic risk group (P = 0.006). Compared with the low genetic risk group, the high genetic risk group had a younger age of diagnosis by 3.7 years (SD, 1.0 years; P < 0.001), more family members affected by 0.46 members (SD, 0.11 members; P < 0.001), and higher rates of incisional surgery (odds ratio, 1.5; 95% confidence interval, 1.1-2.0; P = 0.007). No statistically significant difference was found in mean deviation. We further replicated the maximum IOP, number of family members affected by glaucoma, and treatment intensity (number of medications) results in the early POAG cohort (P ≤ 0.01). CONCLUSIONS: The IOP PRS was correlated positively with maximum IOP, disease severity, need for surgery, and number of affected family members. Genes acting via IOP-mediated pathways, when considered in aggregate, have clinically important and reproducible implications for glaucoma patients and their close family members.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Qassim A, Souzeau E, Siggs OM, et al. An Intraocular Pressure Polygenic Risk Score Stratifies Multiple Primary Open-Angle Glaucoma Parameters Including Treatment Intensity. Ophthalmology. 2020. PMID: 32081492. doi:10.1016/j.ophtha.2019.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。